<PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">39364125</PMID><DateRevised><Year>2024</Year><Month>10</Month><Day>05</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Print">2186-6953</ISSN><JournalIssue CitedMedium="Print"><Volume>43</Volume><Issue>4</Issue><PubDate><Year>2024</Year></PubDate></JournalIssue><Title>Bioscience of microbiota, food and health</Title><ISOAbbreviation>Biosci Microbiota Food Health</ISOAbbreviation></Journal><ArticleTitle>Differences in the human gut microbiota with varying depressive symptom severity scores.</ArticleTitle><Pagination><StartPage>336</StartPage><EndPage>341</EndPage><MedlinePgn>336-341</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.12938/bmfh.2023-049</ELocationID><Abstract><AbstractText>Depression is a prevalent mental health disorder, and its incidence has increased further because of the coronavirus disease 2019 (COVID-19) pandemic. The gut microbiome has been suggested as a potential target for mental health treatment because of the bidirectional communication system between the brain and gastrointestinal tract, known as the gut-brain axis. We aimed to investigate the relationship between the human gut microbiome and depression screening by analyzing the abundance and types of microbiomes among individuals living in Japan, where mental health awareness and support may differ from those in other countries owing to cultural factors. We used a data-driven approach to evaluate the gut microbiome of participants who underwent commercial gut microbiota testing services and completed a questionnaire survey that included a test for scoring depressive tendencies. Our data analysis results indicated that no significant differences in gut microbiome composition were found among the groups based on their depression screening scores. However, the results also indicated the potential existence of a few differentially abundant bacterial taxa. Specifically, the detected bacterial changes in abundance suggest that the Bifidobacteriaceae, Streptococcaceae, and Veillonellaceae families are candidates for differentially abundant bacteria. Our findings should contribute to the growing body of research on the relationship between gut microbiome and mental health, highlighting the potential of microbiome-based interventions for depression treatment. The limitations of this study include the lack of clear medical information on the participants' diagnoses. Future research could benefit from a larger sample size and more detailed clinical information.</AbstractText><CopyrightInformation>©2024 BMFH Press.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Masamura</LastName><ForeName>Yuka</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>The Hotchkiss School, 11 Interlaken Rd, Lakeville, CT 06039, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>College of Fine Arts, Boston University, 855 Commonwealth Ave, Boston, MA 02215, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kubo</LastName><ForeName>Ryuichi</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Cykinso, Inc., 1-36-1 Yoyogi, Shibuya, Tokyo 151-0053, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Midorikawa</LastName><ForeName>Yuki</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Cykinso, Inc., 1-36-1 Yoyogi, Shibuya, Tokyo 151-0053, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shinozaki</LastName><ForeName>Natsuko O</ForeName><Initials>NO</Initials><AffiliationInfo><Affiliation>Cykinso, Inc., 1-36-1 Yoyogi, Shibuya, Tokyo 151-0053, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Watanabe</LastName><ForeName>Satoshi</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Cykinso, Inc., 1-36-1 Yoyogi, Shibuya, Tokyo 151-0053, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Maekawa</LastName><ForeName>Sayumi</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Cykinso, Inc., 1-36-1 Yoyogi, Shibuya, Tokyo 151-0053, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Takeda</LastName><ForeName>Aya K</ForeName><Initials>AK</Initials><AffiliationInfo><Affiliation>Cykinso, Inc., 1-36-1 Yoyogi, Shibuya, Tokyo 151-0053, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ohta</LastName><ForeName>Tazro</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Institute for Advanced Academic Research, Chiba University, 1-33 Yayoicho, Inage, Chiba, Chiba 263-8522, Japan.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Artificial Intelligence Medicine, Graduate School of Medicine, Chiba University, 1-8-1 Inohana, Chuo, Chiba, Chiba 260-8670, Japan.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Database Center for Life Science, Joint-Support Center for Data Science Research, Research Organization of Information and Systems, Mishima, Shizuoka 411-8540, Japan.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>06</Month><Day>12</Day></ArticleDate></Article><MedlineJournalInfo><Country>Japan</Country><MedlineTA>Biosci Microbiota Food Health</MedlineTA><NlmUniqueID>101578264</NlmUniqueID><ISSNLinking>2186-3342</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">16s rRNA</Keyword><Keyword MajorTopicYN="N">direct-to-consumer Mykinso gut-microbiome testing service</Keyword><Keyword MajorTopicYN="N">gut microbiota</Keyword><Keyword MajorTopicYN="N">mental health</Keyword></KeywordList><CoiStatement>None.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>6</Month><Day>27</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>4</Month><Day>30</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>10</Month><Day>4</Day><Hour>11</Hour><Minute>10</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>10</Month><Day>4</Day><Hour>11</Hour><Minute>9</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>10</Month><Day>4</Day><Hour>4</Hour><Minute>19</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>1</Month><Day>1</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39364125</ArticleId><ArticleId IdType="pmc">PMC11444865</ArticleId><ArticleId IdType="doi">10.12938/bmfh.2023-049</ArticleId><ArticleId IdType="pii">2023-049</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>World Health Organization.
Depression. https://www.who.int/news-room/fact-sheets/detail/depression (accessed
2023-04-12)</Citation></Reference><Reference><Citation>United Nations. 2020. COVID-19
and the need for action on mental health. Policy Brief. retrieved from https://www.un.org/sites/un2.un.org/files/un_policy_brief-covid_and_mental_health_final.pdf
(accessed 2023-04-12)</Citation></Reference><Reference><Citation>Reuter JA, Spacek DV, Snyder MP. 2015. High-throughput sequencing technologies. Mol Cell 58: 586–597.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4494749</ArticleId><ArticleId IdType="pubmed">26000844</ArticleId></ArticleIdList></Reference><Reference><Citation>Luna RA, Foster JA. 2015. Gut brain axis: diet microbiota interactions and implications for modulation of anxiety and depression. Curr Opin Biotechnol 32: 35–41.</Citation><ArticleIdList><ArticleId IdType="pubmed">25448230</ArticleId></ArticleIdList></Reference><Reference><Citation>Cheung SG, Goldenthal AR, Uhlemann AC, Mann JJ, Miller JM, Sublette ME. 2019. Systematic review of gut microbiota and major depression. Front Psychiatry 10: 34.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6378305</ArticleId><ArticleId IdType="pubmed">30804820</ArticleId></ArticleIdList></Reference><Reference><Citation>Jiang H, Ling Z, Zhang Y, Mao H, Ma Z, Yin Y, Wang W, Tang W, Tan Z, Shi J, et al. 2015. Altered fecal microbiota composition in patients with major depressive disorder. Brain Behav Immun 48: 186–194.</Citation><ArticleIdList><ArticleId IdType="pubmed">25882912</ArticleId></ArticleIdList></Reference><Reference><Citation>Zheng P, Zeng B, Zhou C, Liu M, Fang Z, Xu X, Zeng L, Chen J, Fan S, Du X, et al. 2016. Gut microbiome remodeling induces depressive-like behaviors through a pathway mediated by the host’s metabolism. Mol Psychiatry 21: 786–796.</Citation><ArticleIdList><ArticleId IdType="pubmed">27067014</ArticleId></ArticleIdList></Reference><Reference><Citation>Naseribafrouei A, Hestad K, Avershina E, Sekelja M, Linløkken A, Wilson R, Rudi K. 2014. Correlation between the human fecal microbiota and depression. Neurogastroenterol Motil 26: 1155–1162.</Citation><ArticleIdList><ArticleId IdType="pubmed">24888394</ArticleId></ArticleIdList></Reference><Reference><Citation>Kanehara A, Umeda M, Kawakami N, World Mental Health Japan Survey Group. 2015. Barriers to mental health care in Japan: results from the World Mental Health Japan Survey. Psychiatry Clin Neurosci 69: 523–533.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4472610</ArticleId><ArticleId IdType="pubmed">25523280</ArticleId></ArticleIdList></Reference><Reference><Citation>Nishijima S, Suda W, Oshima K, Kim SW, Hirose Y, Morita H, Hattori M. 2016. The gut microbiome of healthy Japanese and its microbial and functional uniqueness. DNA Res 23: 125–133.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4833420</ArticleId><ArticleId IdType="pubmed">26951067</ArticleId></ArticleIdList></Reference><Reference><Citation>Debelius J, Song SJ, Vazquez-Baeza Y, Xu ZZ, Gonzalez A, Knight R. 2016. Tiny microbes, enormous impacts: what matters in gut microbiome studies? Genome Biol 17: 217.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5072314</ArticleId><ArticleId IdType="pubmed">27760558</ArticleId></ArticleIdList></Reference><Reference><Citation>Qian XB, Chen T, Xu YP, Chen L, Sun FX, Lu MP, Liu YX. 2020. A guide to human microbiome research: study design, sample collection, and bioinformatics analysis. Chin Med J (Engl) 133: 1844–1855.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7469990</ArticleId><ArticleId IdType="pubmed">32604176</ArticleId></ArticleIdList></Reference><Reference><Citation>Watanabe S, Kameoka S, Shinozaki NO, Kubo R, Nishida A, Kuriyama M, Takeda AK. 2021. A cross-sectional analysis from the Mykinso Cohort Study: establishing reference ranges for Japanese gut microbial indices. Biosci Microbiota Food Health 40: 123–134.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8099632</ArticleId><ArticleId IdType="pubmed">33996369</ArticleId></ArticleIdList></Reference><Reference><Citation>Radloff LS. 1977. The CES-D scale. Appl Psychol Meas 1: 385–401.</Citation></Reference><Reference><Citation>Gay CL, Kottorp A, Lerdal A, Lee KA. 2016. Psychometric limitations of the center for epidemiologic studies—depression scale for assessing depressive symptoms among adults with HIV/AIDS: a Rasch analysis. Depress Res Treat 2016: 2824595.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4794594</ArticleId><ArticleId IdType="pubmed">27042347</ArticleId></ArticleIdList></Reference><Reference><Citation>Bolyen E, Rideout JR, Dillon MR, Bokulich NA, Abnet CC, Al-Ghalith GA, Alexander H, Alm EJ, Arumugam M, Asnicar F, et al. 2019. Reproducible, interactive, scalable and extensible microbiome data science using QIIME 2. Nat Biotechnol 37: 852–857.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7015180</ArticleId><ArticleId IdType="pubmed">31341288</ArticleId></ArticleIdList></Reference><Reference><Citation>Quast C, Pruesse E, Yilmaz P, Gerken J, Schweer T, Yarza P, Peplies J, Glöckner FO. 2013. The SILVA ribosomal RNA gene database project: improved data processing and web-based tools. Nucleic Acids Res 41: D590–D596.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3531112</ArticleId><ArticleId IdType="pubmed">23193283</ArticleId></ArticleIdList></Reference><Reference><Citation>Crusoe MR, Abeln S, Iosup A, Amstutz P, Chilton J, Tijanić N, Ménager H, Soiland-Reyes S, Gavrilović B, Goble C, et al. 2022. Methods included. Commun ACM 65: 54–63.</Citation></Reference><Reference><Citation>Lin H, Peddada SD. 2020. Analysis of compositions of microbiomes with bias correction. Nat Commun 11: 3514.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7360769</ArticleId><ArticleId IdType="pubmed">32665548</ArticleId></ArticleIdList></Reference><Reference><Citation>Kluyver T, Kelley BR, Pérez F, Granger B, Bussonnier M, Frederic J, Kelley K, Hamrick J, Grout J, Corlay S, Ivanov P, Avila D, Abdalla S, Willing C, Jupyter Development Team. 2016. Jupyter Notebooks—a publishing format for reproducible computational workflows. InPositioning and Power in Academic Publishing: Players, Agents and Agendas. IOS Press, Amsterdam, pp. 87–90.</Citation></Reference><Reference><Citation>Tsuboi H, Takakura Y, Tsujiguchi H, Miyagi S, Suzuki K, Nguyen TTT, Pham KO, Shimizu Y, Kambayashi Y, Yoshida N, et al. 2021. Validation of the Japanese version of the Center for Epidemiologic Studies Depression Scale-revised: a preliminary analysis. Behav Sci (Basel) 11: 107.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8389265</ArticleId><ArticleId IdType="pubmed">34436097</ArticleId></ArticleIdList></Reference><Reference><Citation>Vázquez-Baeza Y, Pirrung M, Gonzalez A, Knight R. 2013. EMPeror: a tool for visualizing high-throughput microbial community data. Gigascience 2: 16.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4076506</ArticleId><ArticleId IdType="pubmed">24280061</ArticleId></ArticleIdList></Reference><Reference><Citation>Aizawa E, Tsuji H, Asahara T, Takahashi T, Teraishi T, Yoshida S, Ota M, Koga N, Hattori K, Kunugi H. 2016. Possible association of Bifidobacterium and Lactobacillus in the gut microbiota of patients with major depressive disorder. J Affect Disord 202: 254–257.</Citation><ArticleIdList><ArticleId IdType="pubmed">27288567</ArticleId></ArticleIdList></Reference><Reference><Citation>Li J, Wang J, Wang M, Zheng L, Cen Q, Wang F, Zhu L, Pang R, Zhang A. 2023. Bifidobacterium: a probiotic for the prevention and treatment of depression. Front Microbiol 14: 1174800.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10205982</ArticleId><ArticleId IdType="pubmed">37234527</ArticleId></ArticleIdList></Reference><Reference><Citation>Lin P, Ding B, Feng C, Yin S, Zhang T, Qi X, Lv H, Guo X, Dong K, Zhu Y, et al. 2017. Prevotella and Klebsiella proportions in fecal microbial communities are potential characteristic parameters for patients with major depressive disorder. J Affect Disord 207: 300–304.</Citation><ArticleIdList><ArticleId IdType="pubmed">27741466</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle>